http://orcid.org/0000-0003-2201-5169
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
Cellular senescence is generally defined as irreversible cell-cycle arrest and loss of replicative capacity in virtually all cell types which can have effects on tissues and possibly play a significant role in promoting age-related chronic diseases and cancers. Recently, use of natural bioactive substances such as resveratrol to modify the process of cellular senescence in tissue cells based on specific context has opened an interesting therapeutic perspective in aging and chronic diseases such as cancers. This natural polyphenol is currently being evaluated as a promising anticancer and anti-age-related disease agent. Resveratrol modulates cell cycles and multiple pathways involved in cell growth, apoptosis, senescence, and inflammation, which has mostly observed in laboratory models. In vitro studies indicate that biological effects of resveratrol on cellular senescence or other cell processes may vary depending on cell types and certain contexts. This review aims to discuss the current body of knowledge on the effects of resveratrol on cellular senescence in cancerous and normal cells and its possible effect on prevention of cancers and aging based on in vitro and in vivo studies. It also deals with the putative mechanisms underlying these effects of resveratrol and propounds the controversy on this topic.
Acknowledgment
This study is related to the project NO. 1396/62396 From Student Research Committee, Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran. We also appreciate the Student Research Committee and Research & Technology Chancellor in SBMU for their financial support of this study.
Disclosure Statement
The authors report no conflict of interest.
Additional information
Notes on contributors
Hossein Farhadnejad
H.F. and H.E. contributed in conception and design. H.F. and H.E. contributed in manuscript drafting. H. Z. supervised the study. All authors approved the final version of the manuscript.
Hadi Emamat
H.F. and H.E. contributed in conception and design. H.F. and H.E. contributed in manuscript drafting. H. Z. supervised the study. All authors approved the final version of the manuscript.
Hamid Zand
H.F. and H.E. contributed in conception and design. H.F. and H.E. contributed in manuscript drafting. H. Z. supervised the study. All authors approved the final version of the manuscript.